10x Genomics, Inc. (TXG) Q4 2025 Earnings Call Transcript
Seeking Alpha
February 14, 2026
AI-Generated Deep Dive Summary
10x Genomics, Inc. (TXG) reported strong financial results for Q4 2025, with an EPS of $0.07 that exceeded expectations by $0.11. Revenue reached $166.03 million, reflecting a modest year-over-year growth of 0.61%, which also beat forecasts by $5.68 million. The earnings call, held on February 12, 2026, featured insights from company leaders and notable analysts, underscoring the company's strategic initiatives and market positioning.
The company highlighted its focus on product innovation
Verticals
financemarkets
Originally published on Seeking Alpha on 2/14/2026